NCT05947474 2026-02-10
ORB
Orionis Biosciences Inc
Phase 1 Active not recruiting
Clinical Trials
10 trialsNCT07265921 2025-12-05
Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1 Recruiting
NCT07123415 2025-11-19
A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
Aptabio Therapeutics, Inc.
Phase 1 Recruiting
NCT07196579 2025-09-29
Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors
TCRx Therapeutics Co.Ltd
Phase 1 Not yet recruiting
NCT06985355 2025-09-18
A Study of MHB046C Injection in Patients With Advanced Solid Tumors
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1/2 Recruiting
NCT04877717 2025-03-25
A Study of SHR-A1904 in Patients With Advanced Solid Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1 Active not recruiting
NCT03791112 2025-01-27
A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor
Betta Pharmaceuticals Co., Ltd.
Phase 1 Active not recruiting
NCT03884517 2023-05-01
Clinical Trial of BAT8003 (for Injection) for Patients With Advanced Epithelial Cancer
Bio-Thera Solutions
Phase 1 Terminated
NCT03618043 2019-01-29
Safety and Tolerability of SH-1028 in Patients With Advanced Solid Cancer
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Phase 1 Unknown
NCT01416623 2012-12-21
A Phase I Study of Henatinib in Patients With Advanced Solid Malignancies
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Terminated